Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M903Revenue $M1,205Net Margin (%)1.1Z-Score3.7
Enterprise Value $M1,000EPS $0.4Operating Margin %2.0F-Score4
P/E(ttm))71.5Cash Flow Per Share $23.4Pre-tax Margin (%)1.7Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsN
Price/Sales0.75-y EBITDA Growth Rate %0Current Ratio0.8Lower Leverage y-yN
Price/Cash Flow0.5y-y EBITDA Growth Rate %0ROA % (ttm)1.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)3.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.7ROI % (ttm)-16.6Gross Margin Increase y-yY

Gurus Latest Trades with AMED

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMEDJoel Greenblatt 2014-12-31 Buy 0.01%$19.59 - $30.07
($24.78)
$ 26.828%New holding23,349
AMEDCharles Brandes 2014-12-31 Sold Out $19.59 - $30.07
($24.7)
$ 26.828%Sold Out0
AMEDCharles Brandes 2014-09-30 Reduce-0.03%$15.58 - $21.78
($19.38)
$ 26.8228%Reduce -90.43%15,810
AMEDCharles Brandes 2014-03-31 Reduce-0.01%$14.09 - $16.96
($15.31)
$ 26.8243%Reduce -23.43%165,125
AMEDCharles Brandes 2013-03-31 Add0.03%$10.95 - $13.11
($11.61)
$ 26.8257%Add 515.74%225,885
AMEDJoel Greenblatt 2012-12-31 Sold Out -0.06%$9.65 - $13.56
($11.33)
$ 26.8258%Sold Out0
AMEDCharles Brandes 2012-12-31 Buy $9.65 - $13.56
($11.33)
$ 26.8258%New holding36,685
AMEDJoel Greenblatt 2012-09-30 Reduce-0.06%$11.3 - $15.84
($13.63)
$ 26.8249%Reduce -49.75%65,015
AMEDCharles Brandes 2012-09-30 Sold Out -0.0017%$11.3 - $15.84
($13.63)
$ 26.8249%Sold Out0
AMEDJoel Greenblatt 2012-03-31 Add0.09%$9.56 - $14.66
($11)
$ 26.8259%Add 98.71%144,813
AMEDCharles Brandes 2012-03-31 Buy $9.56 - $14.66
($11)
$ 26.8259%New holding20,195
AMEDDavid Dreman 2011-12-31 Sold Out -0.5%$9.59 - $14.56
($11.75)
$ 26.8256%Sold Out0
AMEDGeorge Soros 2011-12-31 Sold Out -0.0041%$9.59 - $14.56
($11.75)
$ 26.8256%Sold Out0
AMEDCharles Brandes 2011-12-31 Sold Out -0.0021%$9.59 - $14.56
($11.75)
$ 26.8256%Sold Out0
AMEDJoel Greenblatt 2011-09-30 Add0.09%$13.29 - $27.55
($19.78)
$ 26.8226%Add 125.99%64,379
AMEDGeorge Soros 2011-09-30 Reduce-0.07%$13.29 - $27.55
($19.78)
$ 26.8226%Reduce -91.93%16,100
AMEDRonald Muhlenkamp 2011-06-30 Sold Out -1.15%$25.28 - $35.18
($30.9)
$ 26.82-15%Sold Out0
AMEDGeorge Soros 2011-06-30 Buy 0.07%$25.28 - $35.18
($30.9)
$ 26.82-15%New holding199,599
AMEDJoel Greenblatt 2011-06-30 Add0.02%$25.28 - $35.18
($30.9)
$ 26.82-15%Add 21.45%28,488
AMEDCharles Brandes 2011-06-30 Buy $25.28 - $35.18
($30.9)
$ 26.82-15%New holding14,350
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMED is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AMED: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RICCHIUTI PETERDirector 2015-03-13Sell2,003$27.25-4.18view
NETTERVILLE JACK LDirector 2015-03-13Sell10,000$27.2-4.01view
JETER JEFFREY DChief Compliance Officer 2015-03-13Sell11,264$27.02-3.37view
JETER JEFFREY DChief Compliance Officer 2014-08-05Sell2,500$21.819.77view
NORTH TIDE CAPITAL, LLC10% Owner 2014-05-08Buy500,000$13.987.84view
NORTH TIDE CAPITAL, LLC10% Owner 2014-05-01Buy150,000$13.5492.84view
NORTH TIDE CAPITAL, LLC10% Owner 2014-04-29Sell0$092.84view
RICCHIUTI PETERDirector 2014-04-02Sell375$15.3170.54view
RICCHIUTI PETERDirector 2014-03-04Sell400$16.6756.63view
RICCHIUTI PETERDirector 2013-12-03Sell375$15.8964.32view

Press Releases about AMED :

    Quarterly/Annual Reports about AMED:

    News about AMED:

    Articles On GuruFocus.com
    comment on AMED Jun 20 2012 
    well undervalued, st Jan 24 2012 
    “Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 06 2012 
    AMED: Investment Opportunity When the Price Hits an 8-Year Low Dec 27 2011 
    Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
    guru bargain Oct 05 2011 
    Magic Formula Stock: Amedisys (AMED) Aug 05 2011 
    Home Healthcare: Heavily Shorted long Opportunity May 30 2011 
    Amedisys Inc (AMED) CFO Dale E Redman buys 1,000 Shares Aug 25 2010 
    Amedisys Inc Reports Operating Results (10-Q) Aug 09 2010 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Apr 15 2015
    Amedisys Hires Deloitte Consultant as CIO Apr 08 2015
    Amedisys Announces Changes to Executive Leadership Team Apr 07 2015
    AMEDISYS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Apr 07 2015
    Amedisys Announces Changes to Executive Leadership Team Apr 07 2015
    AMEDISYS INC Files SEC form 8-K, Change in Directors or Principal Officers Apr 06 2015
    The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest... Mar 23 2015
    Amedisys Downgraded to Hold on Hospice Struggles - Analyst Blog Mar 11 2015
    Amedisys Q4 Earnings in Line, Revenues Miss the Mark - Analyst Blog Mar 09 2015
    10-K for Amedisys, Inc. Mar 06 2015
    Tenet Healthcare's Business Poised for Growth - Analyst Blog Mar 05 2015
    Amedisys Reports Fourth Quarter Financial Results Mar 04 2015
    Amedisys Inc Earnings Call scheduled for 10:00 am ET today Mar 04 2015
    AMEDISYS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Mar 04 2015
    Amedisys meets 4Q profit forecasts Mar 04 2015
    Amedisys meets 4Q profit forecasts Mar 04 2015
    Q4 2014 Amedisys Inc Earnings Release - Before Market Open Mar 04 2015
    Amedisys Reports Fourth Quarter Financial Results Mar 04 2015
    Amedisys Announces Clinical Excellence in Speech Language Pathology Mar 03 2015
    Amedisys Statement Regarding Inventory and Data Security Reporting Mar 03 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK